Eterna Therapeutics Inc. – NASDAQ:ERNA
Eterna Therapeutics stock price today
$1.68
+1.42
+564.03%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 2 days
Eterna Therapeutics stock price monthly change
-87.66%
month
Eterna Therapeutics stock price quarterly change
-87.66%
quarter
Eterna Therapeutics stock price yearly change
-87.16%
year
Eterna Therapeutics key metrics
Market Cap | 12.70M |
Enterprise value | N/A |
P/E | -0.42 |
EV/Sales | N/A |
EV/EBITDA | 0.03 |
Price/Sales | N/A |
Price/Book | 1.09 |
PEG ratio | N/A |
EPS | -4.25 |
Revenue | N/A |
EBITDA | -19.38M |
Income | -22.89M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeEterna Therapeutics stock price history
Eterna Therapeutics stock forecast
Eterna Therapeutics financial statements
| Jun 2023 | 0 | -4.50M | |
|---|---|---|---|
| Sep 2023 | 51K | -5.59M | -10962.75% |
| Dec 2023 | 17K | -6.15M | -36194.12% |
| Mar 2024 | 47K | -6.64M | -14142.55% |
| 2025 | 32.81M | -57.39M | -174.91% |
|---|---|---|---|
| 2026 | 75.34M | -62.70M | -83.22% |
Analysts Price target
Financials & Ratios estimates
| 2022-08-11 | -0.5538 | -1.2 |
|---|---|---|
| 2022-11-14 | -2.81818 | -2.49 |
| 2023-03-20 | -1.24 | -1.24 |
0%
Yield TTM
| Payout ratio | 0% |
|---|
| 2019 | 0.25% |
|---|---|
| 2020 | |
| 2021 | 0% |
| 2022 | 0.16% |
| 2023 | 0.17% |
| Jun 2023 | 46954000 | 43.08M | 91.77% |
|---|---|---|---|
| Sep 2023 | 52248000 | 48.68M | 93.18% |
| Dec 2023 | 49132000 | 46.89M | 95.46% |
| Mar 2024 | 49657000 | 53.06M | 106.87% |
| Jun 2023 | -3.87M | 0 | 312K |
|---|---|---|---|
| Sep 2023 | -5.82M | 0 | 8.54M |
| Dec 2023 | -4.66M | -19K | 7.70M |
| Mar 2024 | -3.74M | -97K | 1.38M |
Eterna Therapeutics alternative data
| Aug 2023 | 9 |
|---|---|
| Sep 2023 | 9 |
| Oct 2023 | 9 |
| Nov 2023 | 9 |
| Dec 2023 | 9 |
| Jan 2024 | 9 |
| Feb 2024 | 9 |
| Mar 2024 | 8 |
| Apr 2024 | 8 |
| May 2024 | 8 |
| Jun 2024 | 8 |
| Jul 2024 | 8 |
Eterna Therapeutics other data
7.34%
-3.87%
of ERNA is owned by hedge funds
224.00K
-105.80K
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Jul 2023 | 3262235 | 0 |
| Dec 2023 | 7520168 | 0 |
Thursday, 14 November 2024 | ||
| Eterna Therapeutics Regains Compliance with NASDAQ for Continued Listing | globenewswire.com | |
Wednesday, 30 October 2024 | ||
| Eterna Therapeutics Completes Strategic Financial Restructuring with the Aim to Accelerate its Developmental Activities and Long-Term Success | globenewswire.com | |
Thursday, 17 October 2024 | ||
| Eterna Therapeutics and Factor Bioscience Announce Exclusive License and Collaboration Agreement to Accelerate Cell Therapy Development for Oncology, Autoimmune, and Rare Diseases | globenewswire.com | |
Friday, 10 May 2024 | ||
| Eterna Therapeutics to Present at the ASGCT 27th Annual Meeting on Development of Beta 2 Microglobulin-Knockout (B2M-KO) iMSC Line with Enhanced Immunosuppressive Activity and Stealthing Features that May Further Augment the Therapeutic Potential of MSCs in Inflammatory Diseases | GlobeNewsWire |
-
What's the price of Eterna Therapeutics stock today?
One share of Eterna Therapeutics stock can currently be purchased for approximately $1.68.
-
When is Eterna Therapeutics's next earnings date?
Unfortunately, Eterna Therapeutics's (ERNA) next earnings date is currently unknown.
-
Does Eterna Therapeutics pay dividends?
No, Eterna Therapeutics does not pay dividends.
-
How much money does Eterna Therapeutics make?
Eterna Therapeutics has a market capitalization of 12.70M. Eterna Therapeutics made a loss 21.67M US dollars in net income (profit) last year or -$1.24 on an earnings per share basis.
-
What is Eterna Therapeutics's stock symbol?
Eterna Therapeutics Inc. is traded on the NASDAQ under the ticker symbol "ERNA".
-
What is Eterna Therapeutics's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Eterna Therapeutics?
Shares of Eterna Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Eterna Therapeutics have?
As Jul 2024, Eterna Therapeutics employs 8 workers.
-
When Eterna Therapeutics went public?
Eterna Therapeutics Inc. is publicly traded company for more then 34 years since IPO on 29 Aug 1991.
-
What is Eterna Therapeutics's official website?
The official website for Eterna Therapeutics is brooklynitx.com.
-
Where are Eterna Therapeutics's headquarters?
Eterna Therapeutics is headquartered at 10355 Science Center Drive, San Diego, CA.
-
How can i contact Eterna Therapeutics?
Eterna Therapeutics's mailing address is 10355 Science Center Drive, San Diego, CA and company can be reached via phone at +212 5821199.
Eterna Therapeutics company profile:
Eterna Therapeutics Inc.
brooklynitx.comExchange:
NASDAQ
Full time employees:
8
Industry:
Biotechnology
Sector:
Healthcare
Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy technology for the treatment of oncology, blood disorder, and monogenic disease. Brooklyn ImmunoTherapeutics, Inc. is based in Brooklyn, New York.
10355 Science Center Drive
San Diego, CA 92121
San Diego, CA 92121
CIK: 0000748592
ISIN: US1140822099
CUSIP: 114082209
